EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood

Makoto Saito iD, Mary Ellen Gilder iD, Verena Ilona Carrara, Laypaw Archusuksan, Hsa Eh, Naw Eh, Ma Ner, Aye Kyi Win, Laaongsri Niwetphongprai, Urairat Koesukwiwat, Joel Tarning iD, Nicholas J White iD und 2 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf552 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Makoto Saito und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Ramat, Thailand. Hauptthemen laut MEDLINE: Mefloquine, Antimalarials, Quinolines, Fetal Blood. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malaria in pregnancy causes adverse effects on the mother and fetus, requiring effective antimalarial treatment. Understanding the transplacental transfer of antimalarials is vital to assessing fetal safety and the risk of congenital malaria.

Methods

We assessed a triad of blood samples (mother and neonatal capillary, cord) at delivery among women who were treated for uncomplicated malaria with artemether–lumefantrine (AL), artesunate–mefloquine (ASMQ), or dihydroartemisinin–piperaquine (DP) 4–8 weeks before delivery.

Results

Antimalarial drug concentrations at delivery were measured in 90 women (25 AL, 29 ASMQ, 36 DP). Drug concentrations were detectable in neonates at birth at a maximum of 27, 42, and 55 days after the first dose of lumefantrine, mefloquine, and piperaquine, respectively. The blood concentrations were highest in the mother, followed by the neonate, and lowest in cord blood. Piperaquine showed the highest neonate-to-mother (N/M) ratio (geometric mean, 0.98; 95% confidence interval, 0.67–1.44; n = 32) followed by carboxy–mefloquine (0.90; 0.75–1.08; n = 27), desbutyl–lumefantrine (0.44; 0.30–0.65; n = 16), mefloquine (0.42; 0.38–0.47; n = 26), and lumefantrine (0.31; 0.07–1.36; n = 9). Higher maternal body mass index was associated with a lower N/M ratio of desbutyl–lumefantrine. Female neonatal sex and a longer interval following drug administration were associated with higher N/M ratios of carboxy–mefloquine. No increased risk of jaundice was observed.

Conclusions

Antimalarial drugs crossed the placenta variably. Neonatal concentrations ranged from less than half (lumefantrine, mefloquine) to near maternal equivalence (piperaquine). Collection of neonatal capillary samples at birth should be considered in future studies. Summary We compared antimalarial blood concentrations in mothers, neonates, and cords. Neonatal drug concentrations ranged from near maternal equivalence (piperaquine) to less than half (lumefantrine, mefloquine). Cord concentrations may underestimate neonatal exposure. Future studies should consider neonatal capillary sampling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MefloquineAntimalarialsQuinolinesFetal BloodMaternal-Fetal ExchangeMalariaHumansFemalePregnancyInfant, NewbornAdultLumefantrineYoung AdultMalePregnancy Complications, ParasiticArtemisininsPiperazines

Stichwörter der Autor:innen

Thailand-Myanmar borderfetal drug exposuremalaria in pregnancymaternal-fetal drug transfertransplacental passage

Substanzen

piperaquineMefloquineAntimalarialsQuinolinesLumefantrineArtemisininsPiperazines

Autor:innen und Institutionen

  • Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Ramat, Thailand.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Faculty of Medicine, Institute of Global Health, University of Geneva, Geneva, Switzerland.
  • Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Makoto Saito, Mary Ellen Gilder, Joel Tarning, Nicholas J White, Rose McGready

Förderung

  • Wellcome Trust

Zitieren

APA

Saito, M., Gilder, M. E., Carrara, V. I., Archusuksan, L., Eh, H., Eh, N., Ner, M., Win, A. K., Niwetphongprai, L., Koesukwiwat, U., Tarning, J., White, N. J., Nosten, F., & McGready, R. (2026). Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf552

Vancouver

Saito M, Gilder ME, Carrara VI, Archusuksan L, Eh H, Eh N, et al. Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf552

BibTeX
@article{Saito2026,
  author = {Saito, Makoto and Gilder, Mary Ellen and Carrara, Verena Ilona and Archusuksan, Laypaw and Eh, Hsa and Eh, Naw and Ner, Ma and Win, Aye Kyi and Niwetphongprai, Laaongsri and Koesukwiwat, Urairat and Tarning, Joel and White, Nicholas J and Nosten, François and McGready, Rose},
  title = {Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf552}
}
Kostenlos starten →